Core Viewpoint - East China Normal University has announced procurement intentions for 31 items of laboratory equipment, with a total budget of 118 million yuan, expected to be procured in March 2026 [1][2]. Procurement Overview - The procurement includes various advanced instruments such as automated sample preparation workstations, high-frequency high-resolution small animal ultrasound imaging systems, small animal PET-CT imaging systems, small animal SPECT-CT imaging systems, and high-resolution animal DXA bone density meters [2][4]. - The total budget for these instruments is 118 million yuan, indicating significant investment in research capabilities [2]. Detailed Procurement List - The procurement list includes: - Automated sample preparation workstation with a budget of 3.5 million yuan [4]. - High-frequency high-resolution small animal ultrasound imaging system with a budget of 3.8 million yuan, aimed at cardiovascular and tumor-related disease research [4][5]. - Small animal PET-CT imaging system with a budget of 9.93 million yuan, providing advanced technical support for drug screening and disease research [6]. - Small animal SPECT-CT imaging system with a budget of 9.8 million yuan, enhancing research capabilities in various biomedical fields [6]. - High-resolution animal DXA bone density meter with a budget of 1.62 million yuan, improving efficiency in bone density measurement [6]. - Automated sample storage management system with a budget of 2.23 million yuan, facilitating long-term preservation of biological samples [6]. - Single-cell multi-target mass spectrometer with a budget of 7 million yuan, enhancing capabilities in drug development and biomarker research [7]. - Intelligent irradiation system with a budget of 1.5 million yuan, crucial for creating immune-deficient models [8]. Research Implications - The acquisition of these advanced instruments is expected to significantly enhance research efficiency and capabilities at East China Normal University, allowing researchers to focus more on creative and innovative work [4][5]. - The investment in high-end imaging systems and automated platforms reflects a commitment to advancing biomedical research and improving the quality of scientific output [6][7].